In 2022 I-COMET was granted from NCN for more than 2 mln PLN including:
Pharmacogenomics of SGLT2 inhibitors – investigating the role of empagliflozin in epigenetic modification of non-coding RNA – sirtuin – Sodium-glucose cotransporter-2 axis after myocardial infarction. NCN PRELUDIUM 21- PI Anna Nowak, MD.
Non-coding RNAs as regulators of epigenetic modification: a new dimension in cardiovascular and cerebrovascular health. PIs WUM English Division students: Disha Keshwani and Mikolaj Marszalek
Application of metabolomics, proteomics, and bioinformatic tools to determine pathophysiological changes due to endurance training in ultramarathon runners. NCN MINIATURA 6- PI Zofia Wicik, MSc, PhD
Application of next generation sequencing and computational tools to determine non-coding RNAs expression in endurance athletes. NCN PRELUDIUM 20- PI Piotr Szwed, MD
Understanding contribution of platelets and platelet function in epigenetics of Wilson’s Disease. NCN SONATA- PI Ceren Eyileten-Postula, DVM, PhD